BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36248849)

  • 1. The cytokine network in acute myeloid leukemia.
    Luciano M; Krenn PW; Horejs-Hoeck J
    Front Immunol; 2022; 13():1000996. PubMed ID: 36248849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
    Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
    Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.
    Çelik H; Lindblad KE; Popescu B; Gui G; Goswami M; Valdez J; DeStefano C; Lai C; Thompson J; Ghannam JY; Fantoni G; Biancotto A; Candia J; Cheung F; Sukumar G; Dalgard CL; Smith RH; Larochelle A; Dillon LW; Hourigan CS
    Blood Adv; 2020 Jan; 4(2):367-379. PubMed ID: 31985806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation.
    Reikvam H; Hatfield KJ; Fredly H; Nepstad I; Mosevoll KA; Bruserud Ø
    Eur Cytokine Netw; 2012; 23(4):140-53. PubMed ID: 23328436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
    Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
    J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.
    Carey A; Edwards DK; Eide CA; Newell L; Traer E; Medeiros BC; Pollyea DA; Deininger MW; Collins RH; Tyner JW; Druker BJ; Bagby GC; McWeeney SK; Agarwal A
    Cell Rep; 2017 Mar; 18(13):3204-3218. PubMed ID: 28355571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
    Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
    Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
    Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
    Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P
    Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.
    Montesinos JJ; Sánchez-Valle E; Flores-Figueroa E; Martínez-Jaramillo G; Flores-Guzmán P; Miranda-Peralta E; Gutiérrez-Romero M; Mayani H
    Leuk Lymphoma; 2006 Jul; 47(7):1379-86. PubMed ID: 16923572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
    Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z
    Front Immunol; 2023; 14():1315453. PubMed ID: 38292478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.
    Brenner AK; Andersson Tvedt TH; Bruserud Ø
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27845732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
    Boila LD; Sengupta A
    Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitro.
    Braun S; Gerhartz HH; Schmetzer HM
    Ann Hematol; 2000 Jul; 79(7):363-73. PubMed ID: 10965784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.